FDA Approved: PERJETA — Original Application (Genentech, Inc.)

View source ↗

Summary

The FDA approved PERJETA (pertuzumab) from Genentech as the original application for the treatment of HER2-positive metastatic breast cancer in combination with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Perjeta (pertuzumab)

Snippet

ORIG AP for PERJETA (PERTUZUMAB)